Smith Cynthia — SEC Form 4 filings

SEC reporting owner CIK 1609480. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2024-05-30 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AGIOS PHARMACEUTICALS, INC. (AGIO)Director616
Akebia Therapeutics, Inc. (AKBA)Director36
Spero Therapeutics, Inc. (SPRO)Director34
Protara Therapeutics, Inc. (TARA)Director33
Tvardi Therapeutics, Inc. (TVRD)Director22

Form 4 filings — Smith Cynthia

FiledFormIssuerReported transactionsSource
2026-06-254Spero Therapeutics, Inc. (SPRO)Grant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0EDGAR
2026-06-224Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 35,700 @ $0 · Grant/award (A): 53,600 (derivative) @ $0EDGAR
2026-06-164Protara Therapeutics, Inc. (TARA)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2026-06-114Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 6,000 (derivative) @ $0EDGAR
2025-08-134AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,302 @ $0 · Option exercise (M): 2,302 (derivative) @ $0EDGAR
2025-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,816 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0EDGAR
2025-06-164Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR
2025-06-134Protara Therapeutics, Inc. (TARA)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2025-06-114Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 35,700 @ $0 · Grant/award (A): 53,600 (derivative) @ $0EDGAR
2025-04-214Tvardi Therapeutics, Inc. (TVRD)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2024-08-134AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,302 @ $0 · Option exercise (M): 2,302 (derivative) @ $0EDGAR
2024-06-244AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0EDGAR
2024-06-174AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 3,388 @ $0 · Option exercise (M): 3,388 (derivative) @ $0EDGAR
2024-06-104Protara Therapeutics, Inc. (TARA)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-104Akebia Therapeutics, Inc. (AKBA)Grant/award (A): 30,000 @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-05-304Spero Therapeutics, Inc. (SPRO)Grant/award (A): 20,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1609480 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →